Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
18.81
+1.34 (7.67%)
At close: Jul 20, 2026, 4:00 PM EDT
18.90
+0.09 (0.48%)
After-hours: Jul 20, 2026, 7:36 PM EDT

Xencor Revenue

Xencor had revenue of $4.52M in the quarter ending March 31, 2026, a decrease of -86.20%. This brings the company's revenue in the last twelve months to $97.36M, down -23.48% year-over-year. In the year 2025, Xencor had annual revenue of $125.58M with 13.65% growth.

Revenue (ttm)
$97.36M
Revenue Growth
-23.48%
P/S Ratio
14.32
Revenue / Employee
$374,462
Employees
260
Market Cap
1.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025125.58M15.08M13.65%
Dec 31, 2024110.49M-64.12M-36.72%
Dec 31, 2023174.62M10.04M6.10%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 201840.60M-5.55M-12.02%
Dec 31, 201746.15M-62.87M-57.67%
Dec 31, 2016109.02M81.26M292.70%
Dec 31, 201527.76M18.24M191.62%
Dec 31, 20149.52M-652.00K-6.41%
Dec 31, 201310.17M648.00K6.80%
Dec 31, 20129.52M2.68M39.06%
Dec 31, 20116.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
MannKind360.78M
Immatics43.00M
Aktis Oncology8.28M
Inhibrx Biosciences1.30M
Revenue Rankings